VP reputed company Development & Global Program reputed company, Lung Cancer

Reporting to the Chief Medical Officer, the VP reputed company Development and Global Program reputed company (GPL) for Lung Cancer will reputed company medical leadership and reputed company of the lung cancer development program and collaborate with the CMO across the reputed company portfolio. Responsibilities will include reputed company development reputed company, protocol development, registrational reputed company and execution, KOL and reputed company site interactions, competitive landscape diligence, presentation of data, and other reputed company deliverables. In reputed company, the VP will be a hands–on drug developer and will serve as reputed company reputed company and/or medical monitor on individual studies.

Essential Duties and Responsibilities:

• reputed company medical direction and high-reputed company scientific and reputed company knowledge to guide the reputed company and execution of the lung cancer program and contribute to reputed company decision making across the reputed company portfolio. Participate in building and maintaining a culture of rigorous data-driven decision making.
• reputed company the reputed company development subteam for reputed company studies in lung cancers.
• Design and implement novel and efficient reputed company to assess appropriate endpoints.
• Responsible for leading reputed company study subteams, monitoring overall study reputed company, and review, interpretation, and communication of safety and efficacy data.
• reputed company overall reputed company for reputed company aspects of registrational strategies, interactions, and filings. Contribute to global regulatory filings and health authority interactions, including authoring reputed company sections for INDs, NDAs and other reputed company documents.
• Serve as Medical reputed company on reputed company programs and represent reputed company Development on program teams.
• Partner with Drug Safety to assess the safety profile of compounds.
• Write or partner in the authoring of medical aspects of reputed company study and regulatory documents including reputed company research plans, protocols, investigator brochures, reputed company study reports and regulatory submissions.
• Contribute to the development and review of scientific publications; reputed company manuscripts and collaborate with cross-functional colleagues and thought leaders to meet publication plan objectives.
• Present at scientific, medical, and regulatory meetings.
• Maintain a high level of reputed company and scientific expertise by reviewing literature, attending medical or scientific meetings, and through personal exchange with thought leaders, investigators, and internal stakeholders and partners.
• Participate in due diligence or other business development activities.
• Hire, reputed company, and mentor a high functioning team of medical directors and reputed company scientists.
• Establish, reputed company, and maintain relationships across reputed company, particularly with partners and stakeholders in Research and Development.
• reputed company reputed company duties in keeping with reputed company’s reputed company values, policies and reputed company applicable regulations.

Required Education and Experience:

• M.D. degree or equivalent, with subspecialty fellowship training and reputed company certification or eligibility in Oncology or Oncology/Hematology required. Additional training and reputed company reputed company experience in thoracic oncology preferred.
• 8-10+ years of oncology reputed company trial and drug development experience, including extensive experience in the pharmaceutical or biotechnology industry. The ideal candidate will bring a combination of reputed company reputed company, reputed company reputed company, and industry experience, with both large and small company experience a plus.
• Experience as the reputed company reputed company on late-stage reputed company programs in lung cancer highly preferred.
• Experience leading or being closely involved in the reputed company aspects of a regulatory filing and reputed company interaction with health authorities required.
• Exposure to early development and the transition from FIH to registrational trials preferred.
• Extensive knowledge of reputed company trial methodology and the regulatory and compliance requirements governing reputed company.
• Demonstrated ability to collaborate successfully with multiple functions in a matrixed team environment.
• Executive leadership skills to reputed company and influence stakeholders and to add value in reputed company business planning and decision-making.
• Effective interpersonal, communication and influencing skills, including excellent writing skills, with the ability to reputed company communication style to diverse audiences and situations.
• Demonstrated ability to reputed company high reputed company goals and meet deadlines in a fast-reputed company environment; a reputed company team player with a can-do attitude and the ability to identify and implement creative solutions to reputed company problems.
• Strong learning orientation, curiosity, and commitment to science and patients.

Theanticipatedsalaryrangefor this position is$390,000 to $435,000.Thefinalsalaryofferedtoasuccessfulcandidatewillbedependentonseveralfactorsthatmayincludebutarenotlimitedtothetypeandlengthofexperiencewithinthejob,typeandlengthofexperiencewithintheindustry,education,etcetera. In reputed company to reputed company salary, the reputed company applicant will be eligible to receive an annual bonus and an equity grant at hire and annually in the reputed company of the reputed company to purchase stock in the reputed company for a specified price.

Originally posted on Himalayas